IFNG and cancer: Lipopolysaccharides and cytokines like IL-1β and interferon-gamma [IFN-γ] activate the immune system to combat the threats to cellular systems [23], but in cancer cells, as we show here, IL-1β manipulates this evolutionarily protective property of the immune system toward malignant transformation of normal cells into cancer cells.